Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.62 +0.24 (+7.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lexeo Therapeutics (LXEO) Long-Term Debt Repayments (2022 - 2026)

Updated

Lexeo Therapeutics (LXEO) recorded Long-Term Debt Repayments of $142,000 in Q2 2026, up 16.4% from $122,000 a year earlier and up 17.4% from the prior quarter.

Analysis

Lexeo Therapeutics (LXEO) Long-Term Debt Repayments (2022 - 2026) Analysis & Trends

On a TTM basis, Lexeo Therapeutics' Long-Term Debt Repayments came in at $515,000 as of Jun 30, 2026, up 1.4% year-over-year; for FY2025, it was $533,000, up 30.0% from FY2024.

  • Annual Long-Term Debt Repayments has a three-year compound annual growth rate of 48.4% (FY2022 to FY2025).
  • Across earlier years, Long-Term Debt Repayments came in at $410,000 in FY2024 (-3.5%), $425,000 in FY2023 (+160.7%) and $163,000 in FY2022.
  • Quarterly Long-Term Debt Repayments has ranged from $36,000 in Q3 2022 to $169,000 in Q4 2025 over the past five years.
  • On a year-over-year basis, Long-Term Debt Repayments rose in six of the last eight quarters, with growth averaging 17.2%.
  • Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 197.2% in Q3 2023, against a decline of 28.2% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $121,000 (Q1 2026), $169,000 (Q4 2025) and $83,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lexeo Therapeutics 265.74 Mn 265.74 Mn - 142,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142,000.00
Mar 31, 2026 121,000.00
Dec 31, 2025 169,000.00
Sep 30, 2025 83,000.00
Jun 30, 2025 122,000.00
Mar 31, 2025 159,000.00
Dec 31, 2024 116,000.00
Sep 30, 2024 111,000.00
Jun 30, 2024 74,000.00
Mar 31, 2024 109,000.00
Dec 31, 2023 105,000.00
Sep 30, 2023 107,000.00
Jun 30, 2023 103,000.00
Mar 31, 2023 110,000.00
Dec 31, 2022 108,000.00
Sep 30, 2022 36,000.00
API Access

Lexeo Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LXEO&period=max&api_key=YOUR_API_KEY